EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudie

Assessment of continuous low-dose and high-dose burst of inhaled nitric oxide in spontaneously breathing COVID-19 patients: A randomized controlled trial

Nikolay O Kamenshchikov, Bijan Safaee Fakhr, Igor V Kravchenko, Andrey Yu Dish, Yuri K Podoksenov, Boris N Kozlov, Tatiana P Kalashnikova, Mark A Tyo, Nina D Anfinogenova, Alla A Boshchenko, Lorenzo Berra

Nitric Oxide · 2024

DOI: 10.1016/j.niox.2024.06.003 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nitric Oxide, 2024. Verfasst von Nikolay O Kamenshchikov und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences", 634012, Tomsk, Russia. Hauptthemen laut MEDLINE: Nitric Oxide, COVID-19 Drug Treatment, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: NOK Foundation, Russian Academy of Sciences, Ministry of Health of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Inhaled nitric oxide (iNO) showed to improve oxygenation at low doses by reducing intrapulmonary shunt and to display antiviral properties at high doses. To assess the safety and potential benefits, we designed an exploratory clinical trial comparing low-dose with intermittent high-dose iNO to only intermittent high-dose iNO in hypoxemic COVID-19 patients. METHODS: In this single-center interventional non-inferiority randomized trial (ClinicalTrials.gov, NCT04476992), twenty oxygen-dependent COVID-19 patients were randomly assigned to the high-dose (200 ppm for 30 min) + continuous low-dose (20 ppm) iNO group (iNO200/20) or the high-dose iNO group (iNO200). Methemoglobinemia (MetHb) assessed 48 h after iNO initiation was the primary endpoint. Reverse-transcription polymerase chain reaction for SARS-CoV-2, inflammatory markers during hospitalization, and heart ultrasounds during the iNO200 treatments were evaluated. RESULTS: MetHb difference between iNO groups remained within the non-inferiority limit of 3 %, indicating comparable treatments despite being statistically different (p-value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric OxideCOVID-19 Drug TreatmentCOVID-19HumansMaleAdministration, InhalationFemaleMiddle AgedSARS-CoV-2AgedAdultDose-Response Relationship, Drug

Substanzen

Nitric Oxide

Autor:innen und Institutionen

  • Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences", 634012, Tomsk, Russia.
  • Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Anaesthesia, Harvard Medical School, Boston, MA 02115, USA.
  • Siberian State Medical University, 634050 Tomsk, Russia.
  • Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Anaesthesia, Harvard Medical School, Boston, MA 02115, USA; Respiratory Care Service, Pati…

Förderung

  • NOK Foundation
  • Russian Academy of Sciences
  • Ministry of Health of the Russian Federation
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Kamenshchikov, N. O., Safaee Fakhr, B., Kravchenko, I. V., Dish, A. Y., Podoksenov, Y. K., Kozlov, B. N., Kalashnikova, T. P., Tyo, M. A., Anfinogenova, N. D., Boshchenko, A. A., & Berra, L. (2024). Assessment of continuous low-dose and high-dose burst of inhaled nitric oxide in spontaneously breathing COVID-19 patients: A randomized controlled trial. Nitric Oxide. https://doi.org/10.1016/j.niox.2024.06.003

Vancouver

Kamenshchikov NO, Safaee Fakhr B, Kravchenko IV, Dish AY, Podoksenov YK, Kozlov BN, et al. Assessment of continuous low-dose and high-dose burst of inhaled nitric oxide in spontaneously breathing COVID-19 patients: A randomized controlled trial. Nitric Oxide. 2024. doi:10.1016/j.niox.2024.06.003

BibTeX
@article{Kamenshchikov2024,
  author = {Kamenshchikov, Nikolay O and Safaee Fakhr, Bijan and Kravchenko, Igor V and Dish, Andrey Yu and Podoksenov, Yuri K and Kozlov, Boris N and Kalashnikova, Tatiana P and Tyo, Mark A and Anfinogenova, Nina D and Boshchenko, Alla A and Berra, Lorenzo},
  title = {Assessment of continuous low-dose and high-dose burst of inhaled nitric oxide in spontaneously breathing COVID-19 patients: A randomized controlled trial},
  journal = {Nitric Oxide},
  year = {2024},
  doi = {10.1016/j.niox.2024.06.003}
}
Kostenlos starten →